SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-16-003626
Filing Date
2016-11-10
Accepted
2016-11-10 14:24:45
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-Q boston10q.htm 10-Q 657728
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 17100
3 EXHIBIT 32.1 exh32_1.htm EX-32.1 6959
  Complete submission text file 0001102624-16-003626.txt   2910826

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bthe-20160930.xml EX-101.INS 451500
5 XBRL TAXONOMY EXTENSION SCHEMA bthe-20160930.xsd EX-101.SCH 38517
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bthe-20160930_cal.xml EX-101.CAL 45547
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bthe-20160930_def.xml EX-101.DEF 89368
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bthe-20160930_lab.xml EX-101.LAB 246144
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bthe-20160930_pre.xml EX-101.PRE 186336
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 161987363
SIC: 2834 Pharmaceutical Preparations